NO20043698L - Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life - Google Patents
Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended lifeInfo
- Publication number
- NO20043698L NO20043698L NO20043698A NO20043698A NO20043698L NO 20043698 L NO20043698 L NO 20043698L NO 20043698 A NO20043698 A NO 20043698A NO 20043698 A NO20043698 A NO 20043698A NO 20043698 L NO20043698 L NO 20043698L
- Authority
- NO
- Norway
- Prior art keywords
- age
- organs
- heart failure
- sodium hydrogen
- ace inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10204571 | 2002-02-04 | ||
| PCT/EP2003/000587 WO2003066045A1 (en) | 2002-02-04 | 2003-01-22 | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043698L true NO20043698L (en) | 2004-08-31 |
Family
ID=27674558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043698A NO20043698L (en) | 2002-02-04 | 2004-08-31 | Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1474134B1 (en) |
| JP (1) | JP4733348B2 (en) |
| KR (1) | KR20040083498A (en) |
| CN (1) | CN1319528C (en) |
| AR (1) | AR038387A1 (en) |
| AT (1) | ATE520398T1 (en) |
| AU (1) | AU2003244430A1 (en) |
| BR (1) | BR0307443A (en) |
| CA (1) | CA2474888A1 (en) |
| CO (1) | CO5601009A2 (en) |
| HR (1) | HRP20040702A2 (en) |
| HU (1) | HUP0402593A2 (en) |
| MA (1) | MA27170A1 (en) |
| MX (1) | MXPA04007569A (en) |
| NO (1) | NO20043698L (en) |
| NZ (1) | NZ534479A (en) |
| PE (1) | PE20040188A1 (en) |
| PL (1) | PL370488A1 (en) |
| RS (1) | RS68204A (en) |
| RU (1) | RU2004126702A (en) |
| TW (1) | TW200306850A (en) |
| WO (1) | WO2003066045A1 (en) |
| ZA (1) | ZA200406066B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2795053A1 (en) * | 2010-03-31 | 2011-10-06 | The Hospital For Sick Children | Use of remote ischemic conditioning to improve outcome after myocardial infarction |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0855392A3 (en) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them |
| DE19734693A1 (en) * | 1997-08-11 | 1998-01-22 | Hoechst Marion Roussel De Gmbh | Use of cariporide to treat cardiac and non-cardiac disease |
| DE19737224A1 (en) * | 1997-08-27 | 1999-03-18 | Hoechst Marion Roussel De Gmbh | Pharmaceutical preparation for cardiovascular treatment |
| US6011059A (en) * | 1997-12-24 | 2000-01-04 | Bristol-Myers Squibb Company | Acyl guanidine sodium/proton exchange inhibitors and method |
| DE19859727A1 (en) * | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | The use of inhibitors of the sodium-hydrogen exchanger for the manufacture of a medicament for the prevention of age-related organ dysfunctions, age-related illnesses for the prolongation of life |
-
2003
- 2003-01-22 RU RU2004126702/15A patent/RU2004126702A/en not_active Application Discontinuation
- 2003-01-22 BR BR0307443-9A patent/BR0307443A/en not_active IP Right Cessation
- 2003-01-22 MX MXPA04007569A patent/MXPA04007569A/en not_active Application Discontinuation
- 2003-01-22 KR KR10-2004-7012005A patent/KR20040083498A/en not_active Application Discontinuation
- 2003-01-22 JP JP2003565469A patent/JP4733348B2/en not_active Expired - Fee Related
- 2003-01-22 NZ NZ534479A patent/NZ534479A/en unknown
- 2003-01-22 RS YUP-682/04A patent/RS68204A/en unknown
- 2003-01-22 HU HU0402593A patent/HUP0402593A2/en unknown
- 2003-01-22 PL PL03370488A patent/PL370488A1/en not_active Application Discontinuation
- 2003-01-22 CN CNB03803185XA patent/CN1319528C/en not_active Expired - Fee Related
- 2003-01-22 AT AT03737262T patent/ATE520398T1/en active
- 2003-01-22 AU AU2003244430A patent/AU2003244430A1/en not_active Abandoned
- 2003-01-22 EP EP03737262A patent/EP1474134B1/en not_active Expired - Lifetime
- 2003-01-22 WO PCT/EP2003/000587 patent/WO2003066045A1/en active Application Filing
- 2003-01-22 CA CA002474888A patent/CA2474888A1/en not_active Abandoned
- 2003-01-29 TW TW092101906A patent/TW200306850A/en unknown
- 2003-01-31 AR ARP030100296A patent/AR038387A1/en unknown
- 2003-01-31 PE PE2003000115A patent/PE20040188A1/en not_active Application Discontinuation
-
2004
- 2004-07-27 MA MA27801A patent/MA27170A1/en unknown
- 2004-07-29 ZA ZA200406066A patent/ZA200406066B/en unknown
- 2004-08-03 HR HR20040702A patent/HRP20040702A2/en not_active Application Discontinuation
- 2004-08-03 CO CO04075091A patent/CO5601009A2/en not_active Application Discontinuation
- 2004-08-31 NO NO20043698A patent/NO20043698L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR038387A1 (en) | 2005-01-12 |
| CN1694697A (en) | 2005-11-09 |
| RU2004126702A (en) | 2005-04-20 |
| PE20040188A1 (en) | 2004-05-17 |
| JP2005519072A (en) | 2005-06-30 |
| MXPA04007569A (en) | 2004-11-01 |
| CN1319528C (en) | 2007-06-06 |
| EP1474134B1 (en) | 2011-08-17 |
| EP1474134A1 (en) | 2004-11-10 |
| HRP20040702A2 (en) | 2005-04-30 |
| CO5601009A2 (en) | 2006-01-31 |
| PL370488A1 (en) | 2005-05-30 |
| NZ534479A (en) | 2006-03-31 |
| KR20040083498A (en) | 2004-10-02 |
| CA2474888A1 (en) | 2003-08-14 |
| HUP0402593A2 (en) | 2005-04-28 |
| RS68204A (en) | 2007-02-05 |
| MA27170A1 (en) | 2005-01-03 |
| JP4733348B2 (en) | 2011-07-27 |
| ZA200406066B (en) | 2005-06-08 |
| WO2003066045A1 (en) | 2003-08-14 |
| AU2003244430A1 (en) | 2003-09-02 |
| ATE520398T1 (en) | 2011-09-15 |
| TW200306850A (en) | 2003-12-01 |
| BR0307443A (en) | 2005-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000563A1 (en) | TRIAZOLPYRIDINE INHIBITORS 11-BETA-HYDROXYSTEROID - DEHYDROGENASE TYPE I | |
| EA200970161A1 (en) | DERIVATIVES 1 - (- D-GLYCOPHRANOSYL) -3- (4-CYCLOPROPYLPHENYLMETHYL) -4-HALOGENOINDOL AND THEIR APPLICATION AS SGLT INHIBITORS | |
| NO20065847L (en) | Diphenylimidazopyrimidines and imidazolamines as inhibitors of B-secretase | |
| MXJL06000006A (en) | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases. | |
| MEP13008A (en) | C-aryl glucoside sglt2 inhibitors and method | |
| NO20033742D0 (en) | Omega-aminoalkylamides of R-2-arylpropionic acids as inhibitors of polymophonuclear and mononuclear cells chemotaxis | |
| NO20044763L (en) | 1- (aminoalkyl) -3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands | |
| EA200802329A1 (en) | TRIAZOLE DERIVATIVES II | |
| DK1499311T3 (en) | Substituted benzols and their use as RAF kinase inhibitors | |
| DK1956004T3 (en) | Quinoline derivatives and their use as 5-HT6 ligands | |
| DK1973540T3 (en) | Use of benzo-condensed heterocyclic sulfamide derivatives for the treatment of pain | |
| NO20043580L (en) | Quinazolinone derivatives and their use as CB agonists | |
| WO2004037796A3 (en) | 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives | |
| SE0201940D0 (en) | New combination II | |
| NO20075662L (en) | Roflumilast for the treatment of pulmonary hypertension | |
| ME00549B (en) | Use of il-18 inhibitors for the treatment and/or prevention of heart disease | |
| NO20070250L (en) | S-Tenatoprazole sodium monohydrate salt and its use in the form of a proton pump inhibitor | |
| NO20043698L (en) | Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life | |
| NO20013145L (en) | Use of inhibitors of the sodium hydrogen exchanger for the preparation of a drug for the prevention of organ dysfunction and diseases related to a particular age and for a prolonged life | |
| DK1505871T3 (en) | Conservation of RNA and Morphology in Cells and Tissues | |
| DE60305053D1 (en) | Pyrimidine derivatives as selective COX-2 inhibitors | |
| ATE257384T1 (en) | USE OF CILOBRADINE OR PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT OR PREVENT HEART FAILURE | |
| WO2004037233A3 (en) | Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases | |
| EA200501557A1 (en) | NEW METHOD OF SYNTHESIS (2S) -INDOLIN-2-CARBONIC ACID AND USE IN PERINDOPRIL SYNTHESIS | |
| ATE306267T1 (en) | COMBINATION TREATMENT FOR ACUTE MYOCARDIAL INFARCTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |